Products: Primary Antibodies

Anti-FGF13/FHF2 (N91/27)


 Download Full Datasheet

PRODUCT OPTIONS

Catalog # Option Concentration Price*
Catalog #
75-134
Option
Purified
Concentration
1 mg/mL
Price
$205.00
Catalog #
73-134
Option
TC Supernatant
Concentration
Lot dependent
Price
$180.00

Overview

Brand:

NeuroMab

Antibody Type:

Monoclonal

Host Species:

Mouse

Antibody Isotype:

IgG1

Species Reactivity:

Human Mouse Rat

Applications:
WB Western Blot
IHC Immunohistochemistry
ICC Immunocytochemistry
IP Immunoprecipitation
AT Array Tomography
EM Electron Microscopy
CHIP Chromatin Immunoprecipitation
DB Dot Blot

ICC IP WB

Immunogen:

Fusion protein amino acids 53-245 of human FGF13a (also known as fibroblast growth factor homologous factor 2a or FHF2a, accession number Q92913)
Mouse: 99% identity (192/193 amino acids identical)
Rat: 97% identity (183/188 amino acids identical)
97% identity with FGF13b (184/188 amino acids identical)
>60% identity with FGF11, FGF12 and FGF14

Cross Reactivity:

Cross-reacts with FGF13a and FGF13b Does not cross-react with FGF11, FGF12 or FGF14 expressed in heterologous cells

Protein Name(s):

Fibroblast growth factor 13 (FGF-13) (Fibroblast growth factor homologous factor 2) (FHF-2)

Gene Name(s):

FGF13 FHF2

Antibody Registry ID:

Purified: AB_2104047
TC Supernatant: AB_10675138


Antibody Validation and Application Notes


This antibody has been validated using the following assays:
Western Blot:

This antibody recognizes a single immunoreactive band of expected molecular weight when used to probe lysate from COS cells overexpressing target.

Immunocytochemistry:

This antibody shows the expected staining pattern when used to stain COS cells overexpressing target.

Expected Banding Pattern:

28 kDa


Quality Control


The following quality control assay is performed on each new lot of this antibody to ensure it meets designated performance requirements.

Each new lot of this antibody is tested to confirm that it shows the expected staining pattern when used to stain COS cells overexpressing target.